• Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Lansen Pharmaceutical Holdings Ltd

+ Add to Watchlist

503:HK

3.390 HKD 0.040 1.19%

As of 03:38:47 ET on 07/31/2014.

Snapshot for Lansen Pharmaceutical Holdings Ltd (503)

Open: 3.330 Day's Range: 3.280 - 3.450 Volume: 592,000
Previous Close: 3.350 52wk Range: 2.330 - 4.100 1-Yr Rtn: +49.19%

Stock Chart for 503

No chart data available.
  • 503:HK 3.390
  • 1D
  • 1M
  • 1Y
3.350
Interactive 503 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 503

Current P/E Ratio (ttm) 15.5759
Estimated P/E(12/2014) -
Relative P/E vs. HSI 1.4063
Earnings Per Share (USD) (ttm) 0.0280
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M HKD) 1,402.70
Shares Outstanding (M) 415.00
30 Day Average Volume 537,573
Price/Book (mrq) 1.6406
Price/Sale (ttm) 1.9093
Dividend Indicated Gross Yield 4.52%
Cash Dividend (HKD) 0.0695
Dividend Ex-Date 06/05/2014
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 503

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 503

Lansen Pharmaceutical holdings Ltd. is a pharmaceutical holding company. The Company's subsidiaries produce and sell rheumatic specialty prescription western pharmaceuticals in the Peoples Republic of China.

Liu Ming-BangChief Executive OfficerMui Chi HungCFO/Secretary
Poon Lei YungSenior Vice PresidentZhou RongSenior Vice President
More Company Profile & Key Executives for 503

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil